NEUROVASCULAR DYSFUNCTION IN DIABETIC RATS - POTENTIAL CONTRIBUTION OF AUTOXIDATION AND FREE-RADICALS EXAMINED USING TRANSITION-METAL CHELATING-AGENTS

被引:148
作者
CAMERON, NE
COTTER, MA
机构
[1] Department of Biomedical Sciences, Marischal College, University of Aberdeen
基金
英国惠康基金;
关键词
BLOOD FLOW; DIABETES; FREE RADICALS; METAL CHELATORS; NERVE CONDUCTION;
D O I
10.1172/JCI118104
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Oxygen free radical activity is elevated in diabetes mellitus and has been implicated in the etiology of vascular complications, Recent studies have shown that impaired perfusion of nerve endoneurium is a major cause of nerve fiber dysfunction in experimental diabetes, Free radical scavenger treatment prevents the development of nerve conduction abnormalities in diabetic rats, In vitro experiments suggest that autoxidation reactions of glucose, catalyzed by free transition metal ions, are a potential source of free radicals in diabetes, We investigated whether chronic treatment with deferoxamine and trientine, transition metal chelating agents which can prevent autoxidation, could correct nerve conduction and blood flow changes in streptozotocin-diabetic rats, A 20% reduction in sciatic nerve motor conduction velocity after 2 mo diabetes was 90% ameliorated by 2 wk of treatment with deferoxamine or trientine, Sciatic endoneurial nutritive blood flow was 45% reduced by diabetes, but was completely corrected by treatment, In contrast, transition metal chelation had no effect on blood flow or conduction velocity in nondiabetic rats, Thus, the data support the hypothesis that increased free radical activity by glucose autoxidation as a result of impaired transition metal handling is a major cause of early neurovascular deficits in diabetes.
引用
收藏
页码:1159 / 1163
页数:5
相关论文
共 42 条
[1]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[2]   POTENTIAL USE OF GLUTATHIONE FOR THE PREVENTION AND TREATMENT OF DIABETIC NEUROPATHY IN THE STREPTOZOTOCIN-INDUCED DIABETIC RAT [J].
BRAVENBOER, B ;
KAPPELLE, AC ;
HAMERS, FPT ;
VANBUREN, T ;
ERKELENS, DW ;
GISPEN, WH .
DIABETOLOGIA, 1992, 35 (09) :813-817
[3]   GLYCATION PRODUCTS AND THE PATHOGENESIS OF DIABETIC COMPLICATIONS [J].
BROWNLEE, M .
DIABETES CARE, 1992, 15 (12) :1835-1843
[4]   ADVANCED GLYCOSYLATION PRODUCTS QUENCH NITRIC-OXIDE AND MEDIATE DEFECTIVE ENDOTHELIUM-DEPENDENT VASODILATATION IN EXPERIMENTAL DIABETES [J].
BUCALA, R ;
TRACEY, KJ ;
CERAMI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :432-438
[5]   ALDOSE REDUCTASE INHIBITION, DOPPLER FLUX AND CONDUCTION IN DIABETIC RAT NERVE [J].
CALCUTT, NA ;
MIZISIN, AP ;
KALICHMAN, MW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 251 (01) :27-33
[6]   NERVE BLOOD-FLOW IN EARLY EXPERIMENTAL DIABETES IN RATS - RELATION TO CONDUCTION DEFICITS [J].
CAMERON, NE ;
COTTER, MA ;
LOW, PA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (01) :E1-E8
[7]   THE POTENTIAL CONTRIBUTION OF ENDOTHELIN-1 TO NEUROVASCULAR ABNORMALITIES IN STREPTOZOTOCIN-DIABETIC RATS [J].
CAMERON, NE ;
DINES, KC ;
COTTER, MA .
DIABETOLOGIA, 1994, 37 (12) :1209-1215
[8]   ALDOSE REDUCTASE INHIBITION, NERVE PERFUSION, OXYGENATION AND FUNCTION IN STREPTOZOTOCIN-DIABETIC RATS - DOSE-RESPONSE CONSIDERATIONS AND INDEPENDENCE FROM A MYOINOSITOL MECHANISM [J].
CAMERON, NE ;
COTTER, MA ;
DINES, KC ;
MAXFIELD, EK ;
CAREY, F ;
MIRRLEES, DJ .
DIABETOLOGIA, 1994, 37 (07) :651-663
[9]   ANTIOXIDANT AND PROOXIDANT EFFECTS ON NERVE-CONDUCTION VELOCITY, ENDONEURIAL BLOOD-FLOW AND OXYGEN-TENSION IN NONDIABETIC AND STREPTOZOTOCIN-DIABETIC RATS [J].
CAMERON, NE ;
COTTER, MA ;
ARCHIBALD, V ;
DINES, KC ;
MAXFIELD, EK .
DIABETOLOGIA, 1994, 37 (05) :449-459
[10]   ANTIOXIDANT TREATMENT PREVENTS THE DEVELOPMENT OF PERIPHERAL-NERVE DYSFUNCTION IN STREPTOZOTOCIN-DIABETIC RATS [J].
CAMERON, NE ;
COTTER, MA ;
MAXFIELD, EK .
DIABETOLOGIA, 1993, 36 (04) :299-304